CREFX | CSCIX | CREFX / CSCIX | |
Total Expense Ratio | 0.75 | 1.75 | 43% |
Annual Report Gross Expense Ratio | 0.75 | 1.75 | 43% |
Fund Existence | 9 years | 28 years | - |
Gain YTD | 4.977 | 4.222 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 8.3B | 100% |
Annual Yield % from dividends | 2.83 | 2.49 | 114% |
Returns for 1 year | -1.00 | -1.98 | 51% |
Returns for 3 years | 34.72 | 30.12 | 115% |
Returns for 5 years | 29.97 | 21.85 | 137% |
Returns for 10 years | N/A | 42.59 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 73.43 | N/A | N/A |
Janus Henderson Global Life Sciences T | |||
HILGX | 12.16 | N/A | N/A |
Hennessy Cornerstone Large Growth Instl | |||
BRWCX | 27.52 | N/A | N/A |
MFS Blended Research Growth Eq C | |||
MRFOX | 34.99 | N/A | N/A |
Marshfield Concentrated Opportunity | |||
RICEX | 67.14 | -0.16 | -0.24% |
American Funds Invmt Co of Amer R4 |